1-20 of 32
Jin S. Im
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Inotuzumab Ozogamicin to the Conditioning Regimen of Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed CD22 (+) Lymphoid Malignancies: Long-Term Survival Results

Issa F. Khouri, Kamal Alzahrani, Alison Gulbis, Koji Sasaki, Nitin Jain, Nicholas J. Short, Tapan M. Kadia, May Daher, MD, Hind Rafei, Jin S Im, David Marin, Amanda L. Olson, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A. Srour, Partow Kebriaei, Elizabeth J. Shpall, Hagop M. Kantarjian, Richard E. Champlin, Elias Jabbour
Journal: Blood
Blood (2023) 142 (Supplement 1): 233.
https://doi.org/10.1182/blood-2023-181880
Published: 2023
Journal Articles

Predictors for Survival and Relapse in Patients (pts) with Diffuse Large b-Cell Lymphoma (DLBCL) Treated with Anti-CD19 CAR T-Cell Therapy: A Case for Early Intervention in High-Risks Pts Assessed By Day 30

Issa F. Khouri, Hyunsoo Hwang, Sattva S. Neelapu, Xuemei Wang, Chitra Hosing, Sairah Ahmed, Partow Kebriaei, May Daher, Amanda L. Olson, Paolo Anderlini, Jin S. Im, Jason Westin, Elizabeth J Shpall, Richard E Champlin, Loretta J. Nastoupil
Journal: Blood
Blood (2022) 140 (Supplement 1): 7502–7503.
https://doi.org/10.1182/blood-2022-166930
Published: 2022
Journal Articles

Cord Derived 8F4CAR-iNKT Cells to Prevent Acute Myeloid Leukemia Relapse and Graft Vs. Host Disease after Allogeneic Stem Cell Transplantation

Maison Grefe, Abel Trujillo-Ocampo, Drew Boagni, Jelita Clinton, Hong He, Karen Clise-Dwyer, Hyunwoo Cho, Elizabeth J Shpall, Jeffrey J. Molldrem, Jin S. Im
Journal: Blood
Blood (2022) 140 (Supplement 1): 4517–4518.
https://doi.org/10.1182/blood-2022-167166
Published: 2022
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021
Journal Articles

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Katayoun Rezvani, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2021-146655
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Alison Gulbis, Celina Ledesma, Nitin Jain, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Paolo Anderlini, Qaiser Bashir, MD, May Daher, Partow Kebriaei, MD, David Marin, Rohtesh Mehta, Uday R. Popat, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Jin S. Im, Luis Fayad, Ranjit Nair, MD, Swaminathan P Iyer, MD, Paolo Strati, MD, Felipe Samaniego, MD, Loretta J. Nastoupil, MD, Christopher Flowers, MDMS, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-141985
Published: 2020
Journal Articles

Autologous Vs. Allogeneic Stem Cell Transplantation in Double-Expressor Lymphoma

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Swami P. Iyer, MD, David Marin, Rohtesh Mehta, Amanda L. Olson, Uday R. Popat, MD, Felipe Samaniego, MD, Muzaffar H. Qazilbash, MD, Jin S. Im, Gabriela Rondon, Richard E. Champlin, MD, Alison Gulbis, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138741
Published: 2020
Journal Articles

Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation

Betul Oran, MDMS, Gheath Alatrash, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Chitra Hosing, MD, Uday R. Popat, MD, Jin S. Im, Jessica M McCarty, RN, Jennifer D Ramos, RN, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-134272
Published: 2020
Journal Articles

Risk of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem Cell Transplantation (alloSCT) with Venetoclax- Based Therapy

Akash Mukherjee, Denái R. Milton, MS, Elias Jabbour, MD, Naval Daver, MD, Alison Gulbis, Celina Ledesma, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD MSCE, Farhad Ravandi, MBBS, Tapan M. Kadia, MD, Gheath Alatrash, Amin M. Alousi, MD, May Daher, David Marin, Amanda L. Olson, Betul Oran, MDMS, Partow Kebriaei, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Jin S. Im, Rohtesh Mehta, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137097
Published: 2020
Journal Articles

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Rohtesh S. Mehta, MDMPH,MS, Rima M. Saliba, PhD, Anna Jan, Terri Lynn Shigle, PharmD, Emily Wang, Gabriela Rondon, Yago Nieto, MD, Stefan Ciurea, MD, Betul Oran, MDMS, Jin S. Im, Amanda L. Olson, David Marin, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Paolo Anderlini, Katayoun Rezvani, MD PhD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Amin M. Alousi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-139283
Published: 2020
Journal Articles

Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma

Issa F. Khouri, MD, Denái R. Milton, MS, Celina Ledesma, Elias Jabbour, MD, Qaiser Bashir, Jin S. Im, Luis Fayad, Hun Ju Lee, MD, Ranjit Nair, Loretta J. Nastoupil, MD, Felipe Samaniego, MD, Swami P. Iyer, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Padmanee Sharma, Alison Gulbis
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–11.
https://doi.org/10.1182/blood-2020-138778
Published: 2020
Journal Articles

Transplant Outcomes with Fludarabine and Melphalan in High Risk AML Patients By Donor Types

Betul Oran, MDMS, Stefan O. Ciurea, MD, Rohtesh S. Mehta, MDMPH,MS, Amin M. Alousi, MD, Gabriela Rondon, Uday R. Popat, MD, David Marin, May Daher, Jin S. Im, Partow Kebriaei, MD, Gheath Alatrash, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-134474
Published: 2020
Journal Articles

A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL)

Swami P. Iyer, MD, Jie Xu, MD, Melody R. Becnel, MD, Ranjit Nair, MD, Raphael Steiner, MD, Lei Feng, MS, Hun Ju Lee, MD, Paolo Strati, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Yago Nieto, MD, Chitra Hosing, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ann Vo, Felipe Samaniego, MD, Nathan H. Fowler, MD, Neeraj Saini, MD, Issa F. Khouri, MD, Jin S. Im, Preetesh Jain, MBBS,MDDM,PhD, Luis Fayad, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-143252
Published: 2020
Journal Articles

Single-Cell Characterization of Acute Myeloid Leukemia (AML) and Its Microenvironment Identifies Signatures of Resistance to PD-1 Blockade Based Therapy

Hussein A Abbas, MDPhD, Dapeng Hao, Katarzyna Tomczak, PhD, Praveen Barrodia, Jin S. Im, Patrick K Reville, MD, Zoe Alaniz, Wei Wang, MD PhD, Ruiping Wang, PhD, Feng Wang, PhD, Koichi Takahashi, MD PhD, Jing Ning, PhD, Maomao Ding, Jairo A. Matthews, Latasha Little, BS, Jianhua Zhang, PhD, Sreyashi Basu, PhD, Courtney D. DiNardo, MD MSCE, Tapan M. Kadia, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Michael R Green, PhD, Gheath Alatrash, Padmanee Sharma, James P Allison, PhD, Steven M. Kornblau, MD, Kunal Rai, Linghua Wang, PhD, P Andrew Futreal, PhD, Naval Daver, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–31.
https://doi.org/10.1182/blood-2020-137335
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

Immunologic Predictors for Clinical Responses in Patients with Myelodysplastic Syndromes Treated with Immune Checkpoint Blockade

Sung-Eun Lee, MD PhD, Feng Wang, PhD, Abel Trujillo-Ocampo, PhDMS, Wilfredo Ruiz Vazquez, Hyun-Woo Cho, Koichi Takahashi, MD PhD, Gheath Alatrash, Jeffrey J. Molldrem, Richard E. Champlin, MD, Naval Daver, MD, Hagop M. Kantarjian, MD, P. Andrew Futreal, Guillermo Garcia-Manero, MD, Jin S. Im
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-136963
Published: 2020